PPARGC1A and neoplasm: For example, using Bezafibrate, a PGC-1α agonist, has demonstrated enhanced antitumor immunity by upregulating mitochondrial oxidative phosphorylation (OXPHOS) and inhibiting apoptosis in a mouse tumor model (MC38) with PD-1 blockade23.